.
MergerLinks Header Logo

Announced

Completed

General Atlantic led a $320m Series D round in Biofourmis.

Financials

Edit Data
Transaction Value£251m
Consideration TypeCash
Capital Owned-
Capital Bid For-
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Acquisition

Private Equity

Single Bidder

Completed

Venture Capital

Friendly

Private

Biotechnology

predictive analytics

mhealth

digital health

digital therapeutics

biotechnology

United States

Domestic

Minority

Synopsis

Edit

General Atlantic, a global growth equity firm, led a $320m Series D round in Biofourmis, a provider of virtual care and digital medicine solutions, with participation from CVS Health. "In recent years, we have seen a significant trend towards virtual at-home care, which has become a critical alternative to in-person care, particularly as digital adoption continues to accelerate. Biofourmis is tapping into this global trend with a new approach to remote care management," Sandeep Naik, General Atlantic Managing Director and Head of India & Southeast Asia. On Aug 10, 2022, Intel Capital joined the round.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US